Rita Gelli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rita Gelli has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Francesca Ridi
University of Florence
10 shared publications - Massimo Bonini
Department of Chemistry “Ugo Schiff” and CSGI, University of Florence, via della Lastruccia 3, Sesto Fiorentino, 50019 Florence, Italy
7 shared publications Francesca Ridi
4 shared publications- Piero Baglioni
Department of Chemistry and CSGI, University of Florence, Via della Lastruccia 3, Sesto Fiorentino, Florence 50019, Italy
4 shared publications Piero Baglioni
Department of Chemistry "Ugo Schiff" and CSGI, University of Florence, via della Lastruccia 3, 50019 Sesto Fiorentino, Florence, Italy
3 shared publicationsAnna Dzimitrowicz
2 shared publications
Latest Publications
- Open Access
- 12 November 2026
- Published by Elsevier in Ceramics International
Cold Atmospheric Plasma-Mediated Modification of Nanohydroxyapatite: Effects on Physicochemical Properties and Cytocompatibility
- 12 November 2026
- Published by Elsevier in Ceramics International
Open AccessCold Atmospheric Plasma-Mediated Modification of Nanohydroxyapatite: Effects on Physicochemical Properties and Cytocompatibility
- Open Access
- 16 October 2026
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 12 (11) , 6213-6225
Dual Delivery from a Multilayer Buccal Film: Rational Design of a Combination Product for Localized Treatment of Oral Fibrosis
Oral submucous fibrosis (OSF) is a chronic, progressive, and potentially malignant disorder characterized by severe oral cavity remodeling. The condition is driven by a painful burning sensation and a pathognomonic restriction of mouth opening (trismus), severely diminishing patients’ quality of life. Current clinical management represents a critical bottleneck in patient care, as conventional strategies rely heavily on painful intralesional injections or systemic regimens plagued by localized toxicity and poor compliance. Consequently, there is an urgent demand for localized, noninvasive, and patient-compliant delivery systems capable of sustaining therapeutic drug levels directly at the fibrotic site. To address this challenge, we developed, optimized, and characterized a multilayered buccal film (“sandwich” architecture) combining bupivacaine (Bupi) and pirfenidone (PFD) to achieve an immediate anesthetic effect followed by sustained antifibrotic action. A Design of Experiments (DoE) approach optimized both formulation composition and the critical process parameter (drying rate), yielding a fast-dissolving (FD) layer engineered for rapid Bupi release alongside a slow-dissolving (SD) layer tailored for prolonged PFD dissolution. The resulting monolithic system successfully immobilizes both therapeutics in a stable amorphous state, leveraging macromolecular free volume and modulated surface microtopography to regulate biphasic release kinetics. This work demonstrates the feasibility of engineering kinetically distinct, multilayered buccal films through rational design, providing a translationally viable therapeutic platform for localized management of oral fibrosis.
- 16 October 2026
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 12 (11) , 6213-6225
Open AccessDual Delivery from a Multilayer Buccal Film: Rational Design of a Combination Product for Localized Treatment of Oral Fibrosis
Oral submucous fibrosis (OSF) is a chronic, progressive, and potentially malignant disorder characterized by severe oral cavity remodeling. The condition is driven by a painful burning sensation and a pathognomonic restriction of mouth opening (trismus), severely diminishing patients’ quality of life. Current clinical management represents a critical bottleneck in patient care, as conventional strategies rely heavily on painful intralesional injections or systemic regimens plagued by localized toxicity and poor compliance. Consequently, there is an urgent demand for localized, noninvasive, and patient-compliant delivery systems capable of sustaining therapeutic drug levels directly at the fibrotic site. To address this challenge, we developed, optimized, and characterized a multilayered buccal film (“sandwich” architecture) combining bupivacaine (Bupi) and pirfenidone (PFD) to achieve an immediate anesthetic effect followed by sustained antifibrotic action. A Design of Experiments (DoE) approach optimized both formulation composition and the critical process parameter (drying rate), yielding a fast-dissolving (FD) layer engineered for rapid Bupi release alongside a slow-dissolving (SD) layer tailored for prolonged PFD dissolution. The resulting monolithic system successfully immobilizes both therapeutics in a stable amorphous state, leveraging macromolecular free volume and modulated surface microtopography to regulate biphasic release kinetics. This work demonstrates the feasibility of engineering kinetically distinct, multilayered buccal films through rational design, providing a translationally viable therapeutic platform for localized management of oral fibrosis.
- Open Access
- 15 July 2025
- Published by Elsevier in Materials Today Nano
- Vol. 31
Controlling stability and size of amorphous magnesium calcium phosphate particles
- 15 July 2025
- Published by Elsevier in Materials Today Nano
- Vol. 31
Open AccessControlling stability and size of amorphous magnesium calcium phosphate particles
- Open Access
- 2 June 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (22) , 23121-23128
Setup of an In Vitro Three-Dimensional Stromalized Prostate Cancer Model Using Gelatin Microparticles
Developing three-dimensional (3D) tumor models that accurately mimic the tumor microenvironment (TME) and its heterogeneity remains a significant challenge in preclinical research. Advancing these models holds the potential to improve the study of cancer pathologies in vitro, while reducing dependence on animal models. To tackle this challenge, in this work, we report on the development of an in vitro 3D stromalized prostate cancer model using gelatin porous microparticles as microscaffolds for cell attachment and growth. Gelatin porous microparticles were prepared by a double emulsion method and cross-linked with a biocompatible cross-linking agent, that is, glyceraldehyde, to prevent dissolution under physiological conditions. Then, we developed a stromalized 3D gelatin-based microscaffold biomimicking the interplay between human prostate cancer (PCa) and stromal cells by coculturing 22Rv1 cells and fibroblasts with gelatin porous microparticles. Overall, our results demonstrate the feasibility of gelatin microscaffolds in reproducing a 3D stromalized model of PCa progression (e.g., metabolic reprogramming), resulting from the tumor–stroma interaction. Thus, these systems represent a valuable platform and an effective tool for the study of cancer progression, such as TME biomimetics, while simultaneously offering a valid alternative to minimize the reliance on animal studies in preclinical research.
- 2 June 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (22) , 23121-23128
Open AccessSetup of an In Vitro Three-Dimensional Stromalized Prostate Cancer Model Using Gelatin Microparticles
Developing three-dimensional (3D) tumor models that accurately mimic the tumor microenvironment (TME) and its heterogeneity remains a significant challenge in preclinical research. Advancing these models holds the potential to improve the study of cancer pathologies in vitro, while reducing dependence on animal models. To tackle this challenge, in this work, we report on the development of an in vitro 3D stromalized prostate cancer model using gelatin porous microparticles as microscaffolds for cell attachment and growth. Gelatin porous microparticles were prepared by a double emulsion method and cross-linked with a biocompatible cross-linking agent, that is, glyceraldehyde, to prevent dissolution under physiological conditions. Then, we developed a stromalized 3D gelatin-based microscaffold biomimicking the interplay between human prostate cancer (PCa) and stromal cells by coculturing 22Rv1 cells and fibroblasts with gelatin porous microparticles. Overall, our results demonstrate the feasibility of gelatin microscaffolds in reproducing a 3D stromalized model of PCa progression (e.g., metabolic reprogramming), resulting from the tumor–stroma interaction. Thus, these systems represent a valuable platform and an effective tool for the study of cancer progression, such as TME biomimetics, while simultaneously offering a valid alternative to minimize the reliance on animal studies in preclinical research.
- Open Access
- 16 May 2025
- Published by Elsevier in Surfaces and Interfaces
- Vol. 68
Structural characterization of amorphous calcium phosphate-based calciprotein particles stabilized by proteins
- 16 May 2025
- Published by Elsevier in Surfaces and Interfaces
- Vol. 68
Open AccessStructural characterization of amorphous calcium phosphate-based calciprotein particles stabilized by proteins
- Open Access
- 13 September 2024
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 678 (Pt C) , 595-607
Transitioning the production of lipidic mesophase-based delivery systems from lab-scale to robust industrial manufacturing following a risk-based quality by design approach augmented by artificial intelligence
- 13 September 2024
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 678 (Pt C) , 595-607
Open AccessTransitioning the production of lipidic mesophase-based delivery systems from lab-scale to robust industrial manufacturing following a risk-based quality by design approach augmented by artificial intelligence
- Open Access
- 20 November 2023
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 9 (12) , 6632-6643
Effect of Atmospheric Pressure Plasma Jet Treatments on Magnesium Phosphate Cements: Performance, Characterization, and Applications
Atmospheric pressure plasma treatments are nowadays gaining importance to improve the performance of biomaterials in the orthopedic field. Among those, magnesium phosphate-based cements (MPCs) have recently shown attractive features as bone repair materials. The effect of plasma treatments on such cements, which has not been investigated so far, could represent an innovative strategy to modify MPCs' physicochemical properties and to tune their interaction with cells. MPCs were prepared and treated for 5, 7.5, and 10 min with a cold atmospheric pressure plasma jet. The reactive nitrogen and oxygen species formed during the treatment were characterized. The surfaces of MPCs were studied in terms of the phase composition, morphology, and topography. After a preliminary test in simulated body fluid, the proliferation, adhesion, and osteogenic differentiation of human mesenchymal cells on MPCs were assessed. Plasma treatments induce modifications in the relative amounts of struvite, newberyite, and farringtonite on the surfaces on MPCs in a time-dependent fashion. Nonetheless, all investigated scaffolds show a good biocompatibility and cell adhesion, also supporting osteogenic differentiation of mesenchymal cells.
- 20 November 2023
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 9 (12) , 6632-6643
Open AccessEffect of Atmospheric Pressure Plasma Jet Treatments on Magnesium Phosphate Cements: Performance, Characterization, and Applications
Atmospheric pressure plasma treatments are nowadays gaining importance to improve the performance of biomaterials in the orthopedic field. Among those, magnesium phosphate-based cements (MPCs) have recently shown attractive features as bone repair materials. The effect of plasma treatments on such cements, which has not been investigated so far, could represent an innovative strategy to modify MPCs' physicochemical properties and to tune their interaction with cells. MPCs were prepared and treated for 5, 7.5, and 10 min with a cold atmospheric pressure plasma jet. The reactive nitrogen and oxygen species formed during the treatment were characterized. The surfaces of MPCs were studied in terms of the phase composition, morphology, and topography. After a preliminary test in simulated body fluid, the proliferation, adhesion, and osteogenic differentiation of human mesenchymal cells on MPCs were assessed. Plasma treatments induce modifications in the relative amounts of struvite, newberyite, and farringtonite on the surfaces on MPCs in a time-dependent fashion. Nonetheless, all investigated scaffolds show a good biocompatibility and cell adhesion, also supporting osteogenic differentiation of mesenchymal cells.
- 23 October 2023
- Published by American Chemical Society (ACS) in ACS Applied Polymer Materials
- Vol. 5 (11) , 9192-9202
How to Cross-Link Gelatin: The Effect of Glutaraldehyde and Glyceraldehyde on the Hydrogel Properties
- 23 October 2023
- Published by American Chemical Society (ACS) in ACS Applied Polymer Materials
- Vol. 5 (11) , 9192-9202
How to Cross-Link Gelatin: The Effect of Glutaraldehyde and Glyceraldehyde on the Hydrogel Properties
- Open Access
- 14 August 2023
- Published by MDPI AG in Journal of Functional Biomaterials
- Vol. 14 (8) , 424
An Overview of Magnesium-Phosphate-Based Cements as Bone Repair Materials
In the search for effective biomaterials for bone repair, magnesium phosphate cements (MPCs) are nowadays gaining importance as bone void fillers thanks to their many attractive features that overcome some of the limitations of the well-investigated calcium-phosphate-based cements. The goal of this review was to highlight the main properties and applications of MPCs in the orthopedic field, focusing on the different types of formulations that have been described in the literature, their main features, and the in vivo and in vitro response towards them. The presented results will be useful to showcase the potential of MPCs in the orthopedic field and will suggest novel strategies to further boost their clinical application.
- 14 August 2023
- Published by MDPI AG in Journal of Functional Biomaterials
- Vol. 14 (8) , 424
Open AccessAn Overview of Magnesium-Phosphate-Based Cements as Bone Repair Materials
In the search for effective biomaterials for bone repair, magnesium phosphate cements (MPCs) are nowadays gaining importance as bone void fillers thanks to their many attractive features that overcome some of the limitations of the well-investigated calcium-phosphate-based cements. The goal of this review was to highlight the main properties and applications of MPCs in the orthopedic field, focusing on the different types of formulations that have been described in the literature, their main features, and the in vivo and in vitro response towards them. The presented results will be useful to showcase the potential of MPCs in the orthopedic field and will suggest novel strategies to further boost their clinical application.
- 11 July 2023
- Published by Elsevier in Ceramics International
- Vol. 49 (19) , 31466-31476
Strontium-loaded magnesium phosphate bone cements and effect of polymeric additives
- 11 July 2023
- Published by Elsevier in Ceramics International
- Vol. 49 (19) , 31466-31476
Strontium-loaded magnesium phosphate bone cements and effect of polymeric additives